Heart failure as a risk factor for stroke

Woohyeun Kim, Eung Ju Kim

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Heart failure (HF) is one of the major causes of death worldwide. Despite the high incidence of stroke in patients with HF, there has been a controversy as to whether HF itself is a risk factor for stroke. Recently, there is a great deal of evidence that HF itself increases the risk of stroke. In previous studies, the benefit of warfarin for stroke prevention in patients with HF was offset by the risk of bleeding. In the era of non-vitamin K antagonist oral anticoagulants with low bleeding profiles, we can expect a more effective stroke prevention in patients with HF by selective anticoagulation. The purpose of this review is to describe the relationship between stroke and HF, which could be an unconventional risk factor and a potential intervention target for stroke prevention.

Original languageEnglish
Pages (from-to)33-45
Number of pages13
JournalJournal of Stroke
Volume20
Issue number1
DOIs
Publication statusPublished - 2018 Jan 1

Fingerprint

Heart Failure
Stroke
Hemorrhage
Warfarin
Anticoagulants
Cause of Death
Incidence

Keywords

  • CHADS-VASc score
  • Heart failure
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Heart failure as a risk factor for stroke. / Kim, Woohyeun; Kim, Eung Ju.

In: Journal of Stroke, Vol. 20, No. 1, 01.01.2018, p. 33-45.

Research output: Contribution to journalReview article

Kim, Woohyeun ; Kim, Eung Ju. / Heart failure as a risk factor for stroke. In: Journal of Stroke. 2018 ; Vol. 20, No. 1. pp. 33-45.
@article{76fd1c2e7d6043e7a4cbf84db3d37dfd,
title = "Heart failure as a risk factor for stroke",
abstract = "Heart failure (HF) is one of the major causes of death worldwide. Despite the high incidence of stroke in patients with HF, there has been a controversy as to whether HF itself is a risk factor for stroke. Recently, there is a great deal of evidence that HF itself increases the risk of stroke. In previous studies, the benefit of warfarin for stroke prevention in patients with HF was offset by the risk of bleeding. In the era of non-vitamin K antagonist oral anticoagulants with low bleeding profiles, we can expect a more effective stroke prevention in patients with HF by selective anticoagulation. The purpose of this review is to describe the relationship between stroke and HF, which could be an unconventional risk factor and a potential intervention target for stroke prevention.",
keywords = "CHADS-VASc score, Heart failure, Stroke",
author = "Woohyeun Kim and Kim, {Eung Ju}",
year = "2018",
month = "1",
day = "1",
doi = "10.5853/jos.2017.02810",
language = "English",
volume = "20",
pages = "33--45",
journal = "Journal of Stroke",
issn = "2287-6391",
publisher = "Korean Stroke Society",
number = "1",

}

TY - JOUR

T1 - Heart failure as a risk factor for stroke

AU - Kim, Woohyeun

AU - Kim, Eung Ju

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Heart failure (HF) is one of the major causes of death worldwide. Despite the high incidence of stroke in patients with HF, there has been a controversy as to whether HF itself is a risk factor for stroke. Recently, there is a great deal of evidence that HF itself increases the risk of stroke. In previous studies, the benefit of warfarin for stroke prevention in patients with HF was offset by the risk of bleeding. In the era of non-vitamin K antagonist oral anticoagulants with low bleeding profiles, we can expect a more effective stroke prevention in patients with HF by selective anticoagulation. The purpose of this review is to describe the relationship between stroke and HF, which could be an unconventional risk factor and a potential intervention target for stroke prevention.

AB - Heart failure (HF) is one of the major causes of death worldwide. Despite the high incidence of stroke in patients with HF, there has been a controversy as to whether HF itself is a risk factor for stroke. Recently, there is a great deal of evidence that HF itself increases the risk of stroke. In previous studies, the benefit of warfarin for stroke prevention in patients with HF was offset by the risk of bleeding. In the era of non-vitamin K antagonist oral anticoagulants with low bleeding profiles, we can expect a more effective stroke prevention in patients with HF by selective anticoagulation. The purpose of this review is to describe the relationship between stroke and HF, which could be an unconventional risk factor and a potential intervention target for stroke prevention.

KW - CHADS-VASc score

KW - Heart failure

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85041725408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041725408&partnerID=8YFLogxK

U2 - 10.5853/jos.2017.02810

DO - 10.5853/jos.2017.02810

M3 - Review article

AN - SCOPUS:85041725408

VL - 20

SP - 33

EP - 45

JO - Journal of Stroke

JF - Journal of Stroke

SN - 2287-6391

IS - 1

ER -